T3	Effect 20 28	vitiligo
T6	Treat-Disorder 102 128	chronic active hepatitis C
T5	Treatment 43 97	during the second month of interferon alpha 2a therapy
T7	Duration 50 66	the second month
T8	Drug 70 89	interferon alpha 2a
T4	Adverse_event 34 42	occurred
E1	Adverse_event:T4